Peter Stacpoole

Combined Pharmacologic and AAV Gene Therapy of Pyruvate Dehydrogenase Deficiency

National Institute of Child Health and Human Development · R21

PI · $419.4K · University of Florida

Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019

Food and Drug Administration · R01

Contact PI · $2.5M · University of Florida

Personalized Dosing of Dichloroacetate for the Treatment of Rare and Common Diseases

National Institute of Child Health and Human Development · R42

Contact PI · $4.7M · Medosome Biotec, Llc

Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)

Food and Drug Administration · R01

Contact PI · $2M · University of Florida

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

Principal investigator · Active not recruiting · Phase 2

University of Florida

A Pilot Study of Rapid Haplotyping Procedure for Personalized Dosing of Dichloroacetate (DCA) in Healthy Volunteers

Principal investigator · Completed · Phase 1

University of Florida

13C-Pyruvate Breath Test

Principal investigator · Completed · Phase 1

University of Florida

Pharmacotoxicology of Trichloroethylene Metabolites

Principal investigator · Terminated

University of Florida